TOMA Biosciences
Biotechnology ResearchCalifornia, United States11-50 Employees
TOMA Biosciences is a biotechnology company focused on cancer genomics, working to identify DNA alterations within tumor cells to inform treatment decisions. Its approach emphasizes targeted analysis of tumor DNA and a workflow designed to deliver reliable sequencing data more rapidly while remaining compatible with existing sequencing platforms. This combination aims to help laboratories generate clinically meaningful information that can guide therapy choices for patients. Based in Foster City, California, the company serves researchers and clinicians in oncology seeking actionable genomic insights. In its history, TOMA introduced the COMPASS Tumor Profiling System, representing an integrated workflow from tumor sampling through sequencing, analysis, and reporting. A study conducted by Intermountain Healthcare using TOMA reagent kits reported that cancer genomic testing nearly doubled progression-free survival in patients with advanced cancer.